Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


04.07.2022

2 Am J Gastroenterol
2 Am J Surg
2 Ann Thorac Surg
6 BMC Cancer
1 BMC Ophthalmol
1 BMC Surg
1 Br J Cancer
4 Br J Oral Maxillofac Surg
1 Clin Cancer Res
1 Head Neck
1 Histopathology
1 Laryngoscope
13 Oral Oncol
1 Otolaryngol Head Neck Surg
1 PLoS One
2 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. COTTON CC, Shaheen NJ, Thrift AP
    Surveillance After Treatment of Barrett's Esophagus Benefits Those With High-Grade Dysplasia or Intramucosal Cancer Most.
    Am J Gastroenterol. 2022;117:1056-1062.
    PubMed         Abstract available

  2. SMITH JR, Kamihara J, Church AJ, Asch E, et al
    Thyroid Nodules in Children With Familial Adenomatous Polyposis.
    Am J Gastroenterol. 2022;117:1166-1168.
    PubMed         Abstract available


    Am J Surg

  3. STEINL GK, Stewart LA, McManus C, Lee JA, et al
    Ethanol ablation for the treatment of benign thyroid nodules.
    Am J Surg. 2022;224.
    PubMed         Abstract available

  4. SUTTON W, Crepeau PK, Canner JK, Karzai S, et al
    Impact of the 2015 American thyroid association guidelines on treatment in older adults with low-risk, differentiated thyroid cancer.
    Am J Surg. 2022;224.
    PubMed         Abstract available


    Ann Thorac Surg

  5. CHANG C, Linden PA, Jiang B, Sarode A, et al
    Monitoring for Recurrence Following Esophagectomy.
    Ann Thorac Surg. 2021 Nov 15. pii: S0003-4975(21)01909.
    PubMed         Abstract available

  6. NOIRET B, Branche J, Piessen G
    Uselessness and Danger of Dilating Obstructive Esophageal for Staging Purpose: A Confirmation.
    Ann Thorac Surg. 2022;114:357-358.
    PubMed        


    BMC Cancer

  7. ZHU J, Fang R, Pan Z, Qian X, et al
    Circulating lymphocyte subsets are prognostic factors in patients with nasopharyngeal carcinoma.
    BMC Cancer. 2022;22:716.
    PubMed         Abstract available

  8. LI J, Tang LL, Ma J
    Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    BMC Cancer. 2022;22:714.
    PubMed         Abstract available

  9. HIRAHARA N, Matsubara T, Kaji S, Hayashi H, et al
    Feasibility study of adjuvant chemotherapy with S-1 after curative esophagectomy following neoadjuvant chemotherapy for esophageal cancer.
    BMC Cancer. 2022;22:718.
    PubMed         Abstract available

  10. DEGUCHI S, Tanaka H, Suzuki S, Natsuki S, et al
    Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.
    BMC Cancer. 2022;22:699.
    PubMed         Abstract available

  11. ALMADORI G, Coli A, De Corso E, Mele DA, et al
    Parathyroid hormone-related peptide and parathyroid hormone-related peptide receptor type 1 in locally advanced laryngeal cancer as prognostic indicators of relapse and survival.
    BMC Cancer. 2022;22:704.
    PubMed         Abstract available

  12. ZHOU M, Yang W, Xuan Y, Zou W, et al
    A study protocol of a randomized phase II trial of perioperative chemoimmunotherapy verses perioperative chemoimmunotherapy plus preoperative chemoradiation for locally advanced gastric (G) or gastroesophageal junction (GEJ) adenocarcinoma: the NeoRac
    BMC Cancer. 2022;22:710.
    PubMed         Abstract available


    BMC Ophthalmol

  13. KARLSDOTTIR SB, Johannessen S, Bjerrum NC, Frydkjaer-Olsen U, et al
    Periocular basal cell carcinoma results and surgical outcome during a 5-year period in a larger Danish population.
    BMC Ophthalmol. 2022;22:282.
    PubMed         Abstract available


    BMC Surg

  14. BACK K, Lee J, Cho A, Choe JH, et al
    Is total thyroidectomy with bilateral central neck dissection the only surgery for papillary thyroid carcinoma patients with clinically involved central nodes?
    BMC Surg. 2022;22:251.
    PubMed         Abstract available


    Br J Cancer

  15. MASUKUME G, Mmbaga BT, Dzamalala CP, Mlombe YB, et al
    A very-hot food and beverage thermal exposure index and esophageal cancer risk in Malawi and Tanzania: findings from the ESCCAPE case-control studies.
    Br J Cancer. 2022 Jun 29. pii: 10.1038/s41416-022-01890.
    PubMed         Abstract available


    Br J Oral Maxillofac Surg

  16. ADAM D, Kyzas P, Vassiliou L
    Text-to-speech apps: empowering communication in head and neck patients.
    Br J Oral Maxillofac Surg. 2022;60:664-665.
    PubMed        

  17. ZHAO J, Zhang Y, Zheng X
    Clinicopathological characteristics of papillary thyroid cancer located in the isthmus with Delphian lymph node metastasis.
    Br J Oral Maxillofac Surg. 2022;60:635-638.
    PubMed         Abstract available

  18. ZUBAIR F, McMahon J, Kryklyas G, Wicks C, et al
    Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
    Br J Oral Maxillofac Surg. 2022;60:589-595.
    PubMed         Abstract available

  19. KENNERLEY AJ, Mitchell DA, Sebald A, Watson I, et al
    Real-time magnetic resonance imaging: mechanics of oral and facial function.
    Br J Oral Maxillofac Surg. 2022;60:596-603.
    PubMed         Abstract available


    Clin Cancer Res

  20. ZHANG Z, Wu B, Peng G, Xiao G, et al
    Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial.
    Clin Cancer Res. 2022 Jun 29:OF1-OF9. doi: 10.1158/1078-0432.CCR-22-0666.
    PubMed         Abstract available


    Head Neck

  21. HO CM, Chen YH, Hsu WH, Wang WY, et al
    Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnosed oral cancer patients with different stages in Taiwan.
    Head Neck. 2022 Jun 25. doi: 10.1002/hed.27123.
    PubMed         Abstract available


    Histopathology

  22. KOUZU K, Nearchou IP, Kajiwara Y, Tsujimoto H, et al
    Deep learning-based classification of desmoplastic reaction on H&E predicts poor prognosis in esophageal squamous cell carcinoma.
    Histopathology. 2022 Jun 27. doi: 10.1111/his.14708.
    PubMed         Abstract available


    Laryngoscope

  23. LEE MY, Belfiglio M, Zeng J, Fleming CW, et al
    Primary Total Laryngectomy versus Organ Preservation for Locally Advanced T3/T4a Laryngeal Cancer.
    Laryngoscope. 2022 Jun 26. doi: 10.1002/lary.30254.
    PubMed         Abstract available


    Oral Oncol

  24. REVATHI D, Dhanraj G, Ashok V
    Immune check point inhibitors: A promising therapeutic approach in oral cancer.
    Oral Oncol. 2022;132:105977.
    PubMed        

  25. SHREE HARINI K, Ezhilarasan D, Lakshmi T
    Novel fibroblast growth factor receptor inhibitors: Potential therapeutic approach in oral cancer treatment.
    Oral Oncol. 2022;132:105983.
    PubMed        

  26. ALESSANDRINI L, Ferrari M, Taboni S, Sbaraglia M, et al
    Tumor-stroma ratio, neoangiogenesis and prognosis in laryngeal carcinoma. A pilot study on preoperative biopsies and matched surgical specimens.
    Oral Oncol. 2022;132:105982.
    PubMed         Abstract available

  27. BABU S, Krishnan M, Priya Veeraraghavan V, Jayaraman S, et al
    Role of salivary miRNAs in the diagnosis and prognosis of head and neck squamous cell carcinoma.
    Oral Oncol. 2022;132:105993.
    PubMed        

  28. BALACHANDER K, Paramasivam A
    Anti-PD-1 agent: A promising immunotherapy drug for oral cancer?
    Oral Oncol. 2022;132:105997.
    PubMed        

  29. MISRA SR, Das R
    Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!
    Oral Oncol. 2022;132:105998.
    PubMed        

  30. DONA MG, Rollo F, Pichi B, Moretto S, et al
    Updates on Human Papillomavirus-driven oropharyngeal squamous cell carcinomas in a southern European country.
    Oral Oncol. 2022;131:105947.
    PubMed        

  31. HAN N, Li X, Wang Y, Li H, et al
    HIF-1alpha induced NID1 expression promotes pulmonary metastases via the PI3K-AKT pathway in salivary gland adenoid cystic carcinoma.
    Oral Oncol. 2022;131:105940.
    PubMed         Abstract available

  32. WU Y, Koyuncu CF, Toro P, Corredor G, et al
    A machine learning model for separating epithelial and stromal regions in oral cavity squamous cell carcinomas using H&E-stained histology images: A multi-center, retrospective study.
    Oral Oncol. 2022;131:105942.
    PubMed         Abstract available

  33. SIVAPERUMAL P, Sekaran S, Kamala K, Ganapathy D, et al
    Marine bioactive compounds as potential therapeutic inhibitor for oral squamous cell carcinoma (OSCC).
    Oral Oncol. 2022;131:105971.
    PubMed        

  34. STANBOULY D, Philipone E, Morlandt AB, Kaleem A, et al
    Adverse events secondary to cetuximab therapy in head & neck cancer therapy and risk factors for serious outcomes.
    Oral Oncol. 2022;131:105952.
    PubMed         Abstract available

  35. ZANOLETTI E, Tealdo G, Franz L, Cazzador D, et al
    From "Extended total parotidectomy" to "Temporo-parotid resection" for locally advanced parotid tumors: Outlining a shift in surgical perspective.
    Oral Oncol. 2022;131:105975.
    PubMed        

  36. LU HJ, Peng CY, Tseng HC, Hsin CH, et al
    Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma.
    Oral Oncol. 2022;131:105951.
    PubMed         Abstract available


    Otolaryngol Head Neck Surg

  37. STEVANOVIC S, Greguric T, Pazanin L, Ivkic B, et al
    Diagnostic Accuracy of Preoperative CT and Endoscopy Staging in Early Laryngeal Cancer.
    Otolaryngol Head Neck Surg. 2022 Jun 28:1945998221109819.
    PubMed         Abstract available


    PLoS One

  38. UEDA T, Yumii K, Urabe Y, Chikuie N, et al
    Swallowing function after transoral surgery for laryngopharyngeal cancer.
    PLoS One. 2022;17:e0270509.
    PubMed         Abstract available


    Radiother Oncol

  39. QIAN D, Chen X, Shang X, Wang Y, et al
    Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II rando
    Radiother Oncol. 2022 Jun 25. pii: S0167-8140(22)04176.
    PubMed         Abstract available

  40. KROESE TE, Christ SM, van Rossum PSN, Burger MDL, et al
    Incidence and survival of patients with oligometastatic esophagogastric cancer: a multicenter cohort study.
    Radiother Oncol. 2022 Jun 23. pii: S0167-8140(22)04173.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: